Neogen Corp. (NEOG)
11.96
-1.05
(-8.07%)
USD |
NASDAQ |
Oct 06, 16:00
13.27
+1.31
(+10.95%)
After-Hours: 20:00
Neogen Shareholders Equity (Quarterly) : 2.093B for May 31, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | 2.093B |
| February 28, 2026 | 2.102B |
| November 30, 2025 | 2.104B |
| August 31, 2025 | 2.119B |
| May 31, 2025 | 2.071B |
| February 28, 2025 | 2.660B |
| November 30, 2024 | 2.669B |
| August 31, 2024 | 3.135B |
| May 31, 2024 | 3.144B |
| February 29, 2024 | 3.146B |
| November 30, 2023 | 3.148B |
| August 31, 2023 | 3.146B |
| May 31, 2023 | 3.134B |
| February 28, 2023 | 3.126B |
| November 30, 2022 | 3.106B |
| August 31, 2022 | 883.80M |
| May 31, 2022 | 887.37M |
| February 28, 2022 | 875.54M |
| November 30, 2021 | 865.48M |
| August 31, 2021 | 855.36M |
| May 31, 2021 | 840.38M |
| February 28, 2021 | 807.68M |
| November 30, 2020 | 777.40M |
| August 31, 2020 | 751.55M |
| May 31, 2020 | 725.18M |
| Date | Value |
|---|---|
| February 29, 2020 | 711.87M |
| November 30, 2019 | 690.92M |
| August 31, 2019 | 660.31M |
| May 31, 2019 | 637.90M |
| February 28, 2019 | 619.92M |
| November 30, 2018 | 602.07M |
| August 31, 2018 | 581.63M |
| May 31, 2018 | 560.18M |
| February 28, 2018 | 541.66M |
| November 30, 2017 | 520.36M |
| August 31, 2017 | 487.02M |
| May 31, 2017 | 471.61M |
| February 28, 2017 | 451.53M |
| November 30, 2016 | 434.74M |
| August 31, 2016 | 417.20M |
| May 31, 2016 | 404.20M |
| February 29, 2016 | 387.87M |
| November 30, 2015 | 377.88M |
| August 31, 2015 | 365.95M |
| May 31, 2015 | 350.97M |
| February 28, 2015 | 336.77M |
| November 30, 2014 | 326.80M |
| August 31, 2014 | 318.90M |
| May 31, 2014 | 306.36M |
| February 28, 2014 | 291.20M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 1.613B |
| QuidelOrtho Corp. | 1.775B |
| Aspira Women's Health, Inc. | -7.256M |
| VolitionRX Ltd. | -32.16M |
| Lucid Diagnostics, Inc. | 10.93M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.394B |
| Total Liabilities (Quarterly) | 1.301B |
| Debt to Equity Ratio | 0.388 |
| Current Ratio | 3.822 |
| Net Debt Paydown Yield | 0.83% |